Applications including "C8"

LT206 - Anaysis of Antioxidant capacity by pre-column HPLC using DPPH radical -

LC Technical Note InertSustainSwift C8
LT205 - Anaysis of stable radical DPPH -

LC Technical Note InertSustainSwift C8
LT200 - InertSustain & Inertsil HPLC Columns for Reversed Phase Separation -

LC Technical Note InertSustain C18 InertSustain AQ-C18 InertSustainSwift C18 InertSustain AX-C18 Inertsil ODS-HL Inertsil ODS-4 Inertsil ODS-3 Inertsil ODS-P Inertsil ODS-EP InertSustain C8 Inertsil C8-4 Inertsil C4 Inertsil WP300 C18 Inertsil WP300 C8 Inertsil WP300 C4 InertSustain PFP InertSustain Phenyl InertSustain Phenylhexyl
LB263 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB094 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB900 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustain C8
LB895 - Analysis of Venlafaxine hydrochloride -

LC InertSearch InertSustainSwift C8
LB856 - Analysis of Lithium lactylate -

LC InertSearch InertSustain C8
MA020 - Hydrocarbons C5-C8 -

Micro GC InertSearch
LB790 - Analysis of Peptides and Proteins -

LC InertSearch ProteoSil
LB706 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -

LC InertSearch InertSustain AQ-C18
LB705 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -

LC InertSearch InertSustain AQ-C18
LB672 - Analysis of Stearyl Glycyrrhetinate -

LC InertSearch InertSustainSwift C8
LB637 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Extended-Release Tablets) -

LC InertSearch InertSustain C8
LB632 - Analysis of Telmisartan and Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LC InertSearch Inertsil C8-3
LB631 - Analysis of Telmisartan and Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LC InertSearch Inertsil C8-3
LB630 - Analysis of Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LC InertSearch Inertsil C8-3
LB629 - Analysis of Telmisartan (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LC InertSearch Inertsil C8-3
LB619 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride) -

LC InertSearch InertSustain C8
LB617 - Analysis of Levocetirizine -

LC InertSearch Inertsil SIL-100A
ST007 - Analysis of Leukotriene B4 in Cultured Luteal Cells -

SPE Technical Note InertSep LSC C8
LT130 - Analysis of Anion Surfactants by LC/MS/MS -

LC Technical Note InertSustain C18 HP Inertsil C8-4 HP
LT108 - Simultaneous Analysis of Organic Fluorine Compounds Using LC/MS/MS -

LC Technical Note InertSustain C18
LT100 - Inertsil HPLC Columns for Reversed Phase Separation (2) -

LC Technical Note InertSustain C18 Inertsil ODS-4 Inertsil ODS-3 Inertsil ODS-2 Inertsil ODS-SP Inertsil ODS-EP Inertsil ODS-P Inertsil WP300 C18 InertSustain C8 Inertsil C8-3 Inertsil C8-4 Inertsil WP300 C8 InertSustain Phenyl Inertsil Ph-3 Inertsil Ph
LT096 - Analysis of Atorvastatin Calcium -

LC Technical Note Inertsil C8-4 Inertsil C8-4 HP
LB541 - Analysis of 6 kinds of Aldehydes Specified in Japanese Offensive Odor Control Law (Detected by Pre-Column Method with DNPH) -

LC InertSearch Inertsil C8-4
LB535 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustainSwift C8
LB534 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustain C8
LB525 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the draft for the Japanese Pharmacopoeia, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB524 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia supplement II, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB523 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the draft for the Japanese Pharmacopoeia, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB483 - Analysis of Minocycline Hydrochloride (Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustainSwift C8
LB472 - Analysis of Tramadol Hydrochloride (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C8
LB471 - Analysis of Tramadol Hydrochloride (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB468 - Analysis of Vitamin K（InertSustainSwift C8） -

LC InertSearch InertSustainSwift C8
LB463 - Analysis of Ibuprofen (Under the Condition of USP 39-NF34, Ibuprofen Oral Suspension) -

LC InertSearch InertSustain C8
LB458 - Analysis of Glyburide (Under the Condition of USP 39-NF34) -

LC InertSearch Inertsil C8
LB448 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 3-Aminophenol, 3-Aminobenzoic acid, Gentisic acid, Salicylic acid, other related substances and total related substance) -

LC InertSearch InertSustain C8
LB282 - Analysis of Povidone (Under the Condition of the Japanese Pharmacopoeia 16th edition, (4) 1-Vinyl-2-pyrrolidone) -

LC InertSearch InertSustain C8
LB264 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB262 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustain C8
LB251 - Analysis of Quetiapine fumarate (Under the Condition of the Japanese Pharmacopoeia, Quetiapine fumarate Tablets) -

LC InertSearch Inertsil C8-4
LB200 - Analysis of Losartan potassium and Hydrochlorothiazide (Under the Condition of USP 35-NF30, Losartan potassium and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB195 - Analysis of Metformin hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB194 - Analysis of Metformin hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB193 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB192 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB191 - Analysis of Metformin hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB190 - Analysis of Metformin hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB189 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB188 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB152 - Analysis of Epinastine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Epinastine Hydrochloride Tablets) -

LC InertSearch Inertsil C8-4
LB150 - Analysis of Liner alkylbenzene sulfonate (Inertsil C8-4 HP) -

LC InertSearch Inertsil C8-4 HP
LB148 - Analysis of Cyanocobalamin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB124 - Analysis of Ipriflavone (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB123 - Analysis of Ipriflavone (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB093 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB072 - Analysis of Ezetimibe (Inertsil C8-4) -

LC InertSearch Inertsil C8-4
LB065 - Analysis of Brotizolam(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C8
LB062 - Analysis of Cetiridine hydrochloride (Under the Condition of Japanese Pharmacopoeia, Cetiridine hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB060 - Analysis of Quetiapine Fumarate (Under the Condition of the Japanese Pharmacopoeia, Quetiapine Fumarate Tablets) -

LC InertSearch Inertsil C8-4
LB059 - Analysis of Quetiapine Fumarate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil C8-4
LB056 - Analysis of Olopatadine hydrochloride(Under the Condition of Japanese Pharmacopoeia, Olopatadine hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB055 - Analysis of Olopatadine hydrochloride (Under the Condition of Japanese Pharmacopoeia, Olopatadine hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB054 - Analysis of Olopatadine hydrochloride(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB044 - Analysis of Pyridine derivatives (InertSustain C8) -

LC InertSearch InertSustain C8
LB040 - Analysis of Phospholipids (InertSustain C8) -

LC InertSearch InertSustain C8
LB030 - Analysis of Vitamin K (InertSustain C8) -

LC InertSearch InertSustain C8
LB020 - Analysis of Losartan Potassium and Hydrochlorothiazide -

LC InertSearch InertSustain C8
LB019 - Analysis of Losartan Potassium and Hydrochlorothiazide -

LC InertSearch Inertsil C8-4
LA990 - Analysis of Proteins (Inertsil WP300 C8) -

LC InertSearch Inertsil WP300 C8
LA984 - Analysis of Proteins (Inertsil WP300 C8) -

LC InertSearch Inertsil WP300 C8
LA963 - Analysis of Analysis of 9 kinds of Phthalates -

LC InertSearch Inertsil C8-4
LA957 - Analysis of Analysis of 14 kinds of Phthalates -

LC InertSearch Inertsil C8-4
LA922 - Analysis of Atorvastatin tablet -

LC InertSearch Inertsil C8-4
LA921 - Analysis of Atorvastatin -

LC InertSearch Inertsil C8-4
LA900 - Analysis of Lincomycin(Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch Inertsil C8-4
LA899 - Analysis of Rifampicin(Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch Inertsil C8-4
LA888 - Analysis of Ascorbic acids -

LC InertSearch Inertsil C8-3
LA872 - Analysis of Vitamin K (Inertsil C8-4) -

LC InertSearch Inertsil C8-4
LA871 - Analysis of Vitamin K (Inertsil C8-3) -

LC InertSearch Inertsil C8-3
LA870 - Analysis of Vitamin K (Inertsil C8) -

LC InertSearch Inertsil C8
LA774 - Analysis of Peptides and proteins (WP300 C8) -

LC InertSearch Inertsil WP300 C8
LA773 - Analysis of Peptides and proteins (WP300 C8) -

LC InertSearch Inertsil WP300 C8
LA763 - Analysis of Vitamin K (Inertsil C8) -

LC InertSearch Inertsil C8
LA671 - Analysis of Protein (Inertsil WP300 C8) -

LC InertSearch Inertsil WP300 C8
LA664 - Analysis of Clindamycin Phosphate (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil C8-4
LA663 - Analysis of Clindamycin Phosphate (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil C8-3
LA651 - Analysis of Vitamin A (Inertsil C8-3) -

LC InertSearch Inertsil C8-3
LA643 - Analysis of Maleic acid and Fumaric acid (Inertsil C8-3) -

LC InertSearch Inertsil C8-3
LA600 - Analysis of Melamine -

LC InertSearch Inertsil C8-3
LA599 - Analysis of Melamine -

LC InertSearch Inertsil C8-3
LA465 - Analysis of Acidic Compounds -

LC InertSearch Inertsil C8-3
LA464 - Analysis of Basic Compounds -

LC InertSearch Inertsil C8-3
LA463 - Analysis of Non-ionic Compounds -

LC InertSearch Inertsil C8-3
LA461 - Analysis of Aromatic Compounds -

LC InertSearch Inertsil C8-3
LA411 - Tryptic Digest of BSA -

LC InertSearch Inertsil WP300 C8
LA409 - Proteins -

LC InertSearch Inertsil WP300 C8
LA354 - Analysis of Amitriptyline -

LC InertSearch Inertsil C8-3
LA352 - Cation surfactants -

LC InertSearch Inertsil C8
LA331 - Analysis of Phthalic acid dialkylester -

LC InertSearch Inertsil C8-3
LA322 - Analysis of p-n-Alkylphenols -

LC InertSearch Inertsil C8-3
LA321 - Analysis of butylphenol isomer -

LC InertSearch Inertsil C8-3
LA299 - Analysis of Acidic Compounds -

LC InertSearch Inertsil C8-3
LA249 - Analysis of γ-Oryzanol -

LC InertSearch Inertsil C8-3
LA223 - Hippuric acid in Urine -

LC InertSearch Inertsil C8
LA179 - Analysis of Scopolamine butylbromide -

LC InertSearch Inertsil C8-3
LA178 - Analysis of Dipyridamole -

LC InertSearch Inertsil C8-3
LA129 - Rhei rhizoma -

LC InertSearch Inertsil C8
LA128 - Diphenhydramine in Medicine -

LC InertSearch Inertsil C8
LA126 - Organic acids -

LC InertSearch Inertsil C8-3
LA121 - Organic acids -

LC InertSearch Inertsil C8-3
LA120 - Organic acids -

LC InertSearch Inertsil C8-3
LA119 - Organic acids -

LC InertSearch Inertsil C8-3
LA109 - Organic acids -

LC InertSearch Inertsil C8
LA106 - Aromatic Organic acids -

LC InertSearch Inertsil C8
LA086 - Analysis of Aflatoxin -

LC InertSearch Inertsil C8-3
LA038 - Vitamins -

LC InertSearch Inertsil C8-3
LA024 - Vitamins -

LC InertSearch Inertsil C8-3
LA005 - PTC-Amino acids in Soy-sauce -

LC InertSearch Inertsil C8

Applications including "C8"

LT206 - Anaysis of Antioxidant capacity by pre-column HPLC using DPPH radical -

LT205 - Anaysis of stable radical DPPH -

LT200 - InertSustain & Inertsil HPLC Columns for Reversed Phase Separation -

LB263 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LB094 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LB900 - Analysis of Fesoterodine Fumarate -

LB895 - Analysis of Venlafaxine hydrochloride -

LB856 - Analysis of Lithium lactylate -

MA020 - Hydrocarbons C5-C8 -

LB790 - Analysis of Peptides and Proteins -

LB706 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -

LB705 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -

LB672 - Analysis of Stearyl Glycyrrhetinate -

LB637 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Extended-Release Tablets) -

LB632 - Analysis of Telmisartan and Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LB631 - Analysis of Telmisartan and Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LB630 - Analysis of Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LB629 - Analysis of Telmisartan (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LB619 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride) -

LB617 - Analysis of Levocetirizine -

ST007 - Analysis of Leukotriene B4 in Cultured Luteal Cells -

LT130 - Analysis of Anion Surfactants by LC/MS/MS -

LT108 - Simultaneous Analysis of Organic Fluorine Compounds Using LC/MS/MS -

LT100 - Inertsil HPLC Columns for Reversed Phase Separation (2) -

LT096 - Analysis of Atorvastatin Calcium -

LB541 - Analysis of 6 kinds of Aldehydes Specified in Japanese Offensive Odor Control Law (Detected by Pre-Column Method with DNPH) -

LB535 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -

LB534 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -

LB525 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the draft for the Japanese Pharmacopoeia, Telmisartan and Hydrochlorothiazide Tablets) -

LB524 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia supplement II, Telmisartan and Hydrochlorothiazide Tablets) -

LB523 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the draft for the Japanese Pharmacopoeia, Telmisartan and Hydrochlorothiazide Tablets) -

LB483 - Analysis of Minocycline Hydrochloride (Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LB472 - Analysis of Tramadol Hydrochloride (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LB471 - Analysis of Tramadol Hydrochloride (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LB468 - Analysis of Vitamin K（InertSustainSwift C8） -

LB463 - Analysis of Ibuprofen (Under the Condition of USP 39-NF34, Ibuprofen Oral Suspension) -

LB458 - Analysis of Glyburide (Under the Condition of USP 39-NF34) -

LB448 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 3-Aminophenol, 3-Aminobenzoic acid, Gentisic acid, Salicylic acid, other related substances and total related substance) -

LB282 - Analysis of Povidone (Under the Condition of the Japanese Pharmacopoeia 16th edition, (4) 1-Vinyl-2-pyrrolidone) -

LB264 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LB262 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LB251 - Analysis of Quetiapine fumarate (Under the Condition of the Japanese Pharmacopoeia, Quetiapine fumarate Tablets) -

LB200 - Analysis of Losartan potassium and Hydrochlorothiazide (Under the Condition of USP 35-NF30, Losartan potassium and Hydrochlorothiazide Tablets) -

LB195 - Analysis of Metformin hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB194 - Analysis of Metformin hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB193 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB192 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB191 - Analysis of Metformin hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB190 - Analysis of Metformin hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB189 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB188 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB152 - Analysis of Epinastine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Epinastine Hydrochloride Tablets) -

LB150 - Analysis of Liner alkylbenzene sulfonate (Inertsil C8-4 HP) -

LB148 - Analysis of Cyanocobalamin (Under the Condition of the Japanese Pharmacopoeia) -

LB124 - Analysis of Ipriflavone (Under the Condition of the Japanese Pharmacopoeia) -

LB123 - Analysis of Ipriflavone (Under the Condition of the Japanese Pharmacopoeia) -

LB093 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LB072 - Analysis of Ezetimibe (Inertsil C8-4) -

LB065 - Analysis of Brotizolam(Under the Condition of the Japanese Pharmacopoeia) -

LB062 - Analysis of Cetiridine hydrochloride (Under the Condition of Japanese Pharmacopoeia, Cetiridine hydrochloride Tablets) -

LB060 - Analysis of Quetiapine Fumarate (Under the Condition of the Japanese Pharmacopoeia, Quetiapine Fumarate Tablets) -

LB059 - Analysis of Quetiapine Fumarate (Under the Condition of the Japanese Pharmacopoeia) -

LB056 - Analysis of Olopatadine hydrochloride(Under the Condition of Japanese Pharmacopoeia, Olopatadine hydrochloride Tablets) -

LB055 - Analysis of Olopatadine hydrochloride (Under the Condition of Japanese Pharmacopoeia, Olopatadine hydrochloride Tablets) -

LB054 - Analysis of Olopatadine hydrochloride(Under the Condition of Japanese Pharmacopoeia) -

LB044 - Analysis of Pyridine derivatives (InertSustain C8) -

LB040 - Analysis of Phospholipids (InertSustain C8) -

LB030 - Analysis of Vitamin K (InertSustain C8) -

LB020 - Analysis of Losartan Potassium and Hydrochlorothiazide -

LB019 - Analysis of Losartan Potassium and Hydrochlorothiazide -

LA990 - Analysis of Proteins (Inertsil WP300 C8) -

LA984 - Analysis of Proteins (Inertsil WP300 C8) -

LA963 - Analysis of Analysis of 9 kinds of Phthalates -

LA957 - Analysis of Analysis of 14 kinds of Phthalates -

LA922 - Analysis of Atorvastatin tablet -

LA921 - Analysis of Atorvastatin -

LA900 - Analysis of Lincomycin(Under the Condition of Japanese Pharmacopoeia 16) -

LA899 - Analysis of Rifampicin(Under the Condition of Japanese Pharmacopoeia 16) -

LA888 - Analysis of Ascorbic acids -